Stage I-III Triple Negative Breast Cancer research hub

Diet-driven gut microbiome and outcome in patients with early-stage triple-negative breast cancer undergoing neoadjuvant chemotherapy and immunotherapy

This study looks at how the 'good' bacteria in our gut might affect treatment for a type of breast cancer called triple-negative breast cancer. Researchers want to see if changes in diet could help improve how well chemotherapy and immunotherapy work.